poziotinib
luye pharma group,spectrum pharmaceuticals
['nsclc', 'poziotinib', 'sclc', 'spectrum pharma']
sppi: saturday release: spectrum pharmaceuticals announces data from poster presentation for poziotinib in nsclc patients with g778_p780dup her2 exon 20 mutations at esmo congress 2022 
Micro caps, Biotech and Solid Companies.investment rules: 1. DD including Financial's 2. Market value. 3. Risk/Reward Ratio. 4. Charts